Study Stopped
recruitement difficulty
Comparative Study of Pathophysiological Mechanisms and Bronchial Response in Occupational Asthma to Wheat Flour and Quaternary Ammonium Compounds During Standardized Bronchial Provocation Tests
1 other identifier
interventional
35
1 country
1
Brief Summary
Occupational asthma (OA) caused by high molecular weight (HMW) substances have been shown to induce predominantly an eosinophilic inflammation. In contrast, OA caused by low molecular weight (LMW) substances results in a neutrophilic inflammation. In addition, data regarding phenotype of lymphocytes in OA caused by HMW and LMW substances are scarce. The use of a new equipment will allow the realization of specific standardized bronchial challenges (BC) to occupational agents. Thus, we propose to study in more detail the cellular mechanisms involved during BC to HMW and LMW occupational agents in a double-blind placebo controlled study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2012
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2012
CompletedFirst Submitted
Initial submission to the registry
January 28, 2013
CompletedFirst Posted
Study publicly available on registry
February 5, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 12, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 12, 2019
CompletedJune 29, 2020
August 1, 2019
7.3 years
January 28, 2013
June 26, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Assessment of cellular inflammation in peripheral blood and induced sputum
Before and after bronchial challenge: assessment of cellular inflammation in peripheral blood and induced sputum, exhaled NO; assessment of peripheral T lymphocyte phenotype.
33 months
Study Arms (2)
Placebo
PLACEBO COMPARATORflour allergen extract or quaternary ammonium compound
ACTIVE COMPARATORInterventions
At Visit 1: Patients are selected and they will receive a metacholine challenge test during and outside of work. After randomization, patients undergo a standardized bronchial challenge test (SCL SCL • • GenaSOL ™ GenaSIC ™) to either an wheat flour allergen extract or didecyldimethylammonium chloride or placebo. Each bronchial challenge test is followed by blood sampling at different time points and induced sputum. The immediate bronchial response and late bronchial response will be recorded.
Eligibility Criteria
You may qualify if:
- For patients with occupational asthma to wheat flour:
- Clinical history,
- A positive skin test to wheat flour and / or specific IgE to wheat flour
- For patients with occupational asthma to quaternary ammonium compounds:
- Clinical history,
- For two types of asthma:
- Patients must have a worsening of bronchial hyperreactivity during work compared to a rest period assessed by a metacholine challenge
- FEV before challenge (nonspecific and specific) must be\> 70%.
You may not qualify if:
- Asthmas:
- no occupational asthma:
- secondary to clinically relevant sensitization to an allergen domestic
- aggravated at work.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hôpitaux Universitaires de Strasbourg
Strasbourg, 67091, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Frédéric De BLAY, MD
University Hospital, Strasbourg, France
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 28, 2013
First Posted
February 5, 2013
Study Start
September 1, 2012
Primary Completion
December 12, 2019
Study Completion
December 12, 2019
Last Updated
June 29, 2020
Record last verified: 2019-08